Nath Bio-Genes

Market Cap: Micro Cap
Industry: Other Agricultural Products
ISIN: INE448G01010
NSEID: NATHBIOGEN
BSEID: 537291

INR

153.44

0.98 (0.64%)

BSENSE

Dec 17

BSE+NSE Vol: 12.72 k

{
  "main_header": {
    "sid": 628630,
    "name": "Nath Bio-Genes",
    "stock_name": "Nath Bio-Genes",
    "full_name": "Nath Bio-Genes (India) Ltd",
    "name_url": "stocks-analysis/nath-bio-genes",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "153.44",
    "chg": 0.98,
    "chgp": "0.64%",
    "dir": 1,
    "prev_price": "152.46",
    "mcapval": "294.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537291,
    "symbol": "NATHBIOGEN",
    "ind_name": "Other Agricultural Products",
    "ind_code": 107,
    "indexname": "",
    "isin": "INE448G01010",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": "12.72 k",
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nath-bio-genes-628630-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Nath Bio-Genes falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nath-bio-genes-fallingrising-3749560",
        "imagepath": "",
        "date": "2025-12-06 01:25:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>On 05-Dec, Nath Bio-Genes closed at ₹142.45, down by ₹3.4 or 2.33%, marking a continuation of a downward trend that has persisted over the last four trading sessions. During this period, the stock has lost nearly 9.84% in value, hitting a fresh 52-week low of ₹140.1 intraday. This decline is further accentuated by the stock’s underperformance against its sector, lagging by 3.08% on the day. The weighted average price indicates that a significant volume of shares traded closer to the day’s low, signalling selling pressure among investors.</p>\n<p>Moreover, Nath Bio-Genes is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish sentiment prevailing..."
      },
      {
        "title": "Nath Bio-Genes (India) Stock Hits 52-Week Low at Rs.140.1 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-india-stock-hits-52-week-low-amidst-continued-downtrend-3749224",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NathBioGenesInd_priceRelatedfactors_3749224.png",
        "date": "2025-12-05 15:53:01",
        "description": "Nath Bio-Genes (India) has reached a fresh 52-week low of Rs.140.1, marking a significant decline amid a sustained downward trend over recent sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s sector and financial metrics."
      },
      {
        "title": "Nath Bio-Genes (India) Stock Hits 52-Week Low at Rs.140.1 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-india-stock-hits-52-week-low-amidst-continued-downtrend-3749223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NathBioGenesInd_priceRelatedfactors_3749223.png",
        "date": "2025-12-05 15:52:59",
        "description": "Nath Bio-Genes (India) has reached a new 52-week low of Rs.140.1, marking a significant decline amid a sustained downward trend over recent sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s financial and operational metrics."
      },
      {
        "title": "Nath Bio-Genes Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3741042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NathBioGenes_mojoScore_3741042.png",
        "date": "2025-12-02 10:09:46",
        "description": "Nath Bio-Genes has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. The company’s recent performance metrics and investor participation trends have contributed to this updated assessment, signalling caution for stakeholders in the Other Agricultural Products sector."
      },
      {
        "title": "Why is Nath Bio-Genes falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nath-bio-genes-fallingrising-3716327",
        "imagepath": "",
        "date": "2025-11-19 23:02:02",
        "description": "As of 19-Nov, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at Rs 160.65, which reflects a decrease of 3.0 points or 1.83%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.72% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of performance against the benchmark, the stock has shown negative returns over various periods, including a year-to-date decline of 14.66% compared to a 9.02% increase in the Sensex. There is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nBroader Market Context: In the context of the broader market, the Agri-Seeds sector has also seen a downturn, with a decline of 5.53%. While Nath Bio-Genes has outperformed its sector by 3.5% toda..."
      },
      {
        "title": "Nath Bio-Genes Q2 FY26: Seasonal Slump Masks Underlying Growth as Stock Struggles",
        "link": "https://www.marketsmojo.com/news/result-analysis/nath-bio-genes-q2-fy26-seasonal-slump-masks-underlying-growth-as-stock-struggles-3716634",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NathBioGenesInd_quaterlyResult_3716634.png",
        "date": "2025-11-15 10:04:35",
        "description": "Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹320.00 crores, reported a consolidated net profit of ₹2.75 crores for Q2 FY26 (Jul-Sep'25), representing a sharp 92.62% quarter-on-quarter decline but a robust 147.75% year-on-year improvement. The dramatic sequential fall reflects the company's highly seasonal business model, where the first quarter typically captures the bulk of annual revenues during the peak agricultural season."
      },
      {
        "title": "How has been the historical performance of Nath Bio-Genes?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-nath-bio-genes-3699328",
        "imagepath": "",
        "date": "2025-11-13 23:32:10",
        "description": "Answer:\nThe historical performance of Nath Bio-Genes shows a consistent growth trend in net sales and profitability over the past four years.\n\nBreakdown:\nNath Bio-Genes has demonstrated a steady increase in net sales, rising from 278.36 crore in March 2022 to 364.91 crore in March 2025. Total operating income followed the same upward trajectory, reaching 364.91 crore in March 2025. The company's total expenditure, excluding depreciation, also increased, amounting to 315.11 crore in March 2025, up from 241.18 crore in March 2022. Operating profit, excluding other income, remained relatively stable, with a slight decrease to 49.80 crore in March 2025 from 49.86 crore in March 2024, while the overall operating profit (PBDIT) increased to 54.35 crore in March 2025. Profit before tax improved significantly from a loss of 63.43 crore in March 2022 to a profit of 40.04 crore in March 2025. Profit after tax also sa..."
      },
      {
        "title": "How has been the historical performance of Nath Bio-Genes?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-nath-bio-genes-3694063",
        "imagepath": "",
        "date": "2025-11-12 23:19:03",
        "description": "Answer:\nThe historical performance of Nath Bio-Genes shows a consistent growth trend in net sales and profitability over the past four years, culminating in the fiscal year ending March 2025.\n\nBreakdown:\nNath Bio-Genes reported net sales of 364.91 Cr in March 2025, an increase from 332.62 Cr in March 2024, 301.36 Cr in March 2023, and 278.36 Cr in March 2022. The total operating income mirrored this growth, reaching 364.91 Cr in March 2025. Total expenditure, excluding depreciation, also rose to 315.11 Cr in March 2025 from 282.76 Cr in March 2024, reflecting increased manufacturing and distribution expenses. Operating profit (PBDIT) was 54.35 Cr in March 2025, slightly up from 50.49 Cr in March 2024, while profit before tax improved to 40.04 Cr from 38.12 Cr. Profit after tax reached 38.06 Cr in March 2025, compared to 36.17 Cr in March 2024, indicating a positive trend in profitability. The earnings per s..."
      },
      {
        "title": "Nath Bio-Genes Faces Shift to Bearish Outlook Amid Declining Investor Confidence",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-stock-downgraded-to-strong-sell-amid-bearish-trends-3688596",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NathBioGenesInd_mojoScore_3688596.png",
        "date": "2025-11-11 08:34:31",
        "description": "Nath Bio-Genes (India) has undergone a recent evaluation adjustment, reflecting a shift in its technical outlook. The company has reported a -10.61% return over the past year and a decline in institutional investor participation. Additionally, it has experienced a -0.69% CAGR growth in operating profits over five years."
      }
    ],
    "total": 132,
    "sid": "628630",
    "stock_news_url": "https://www.marketsmojo.com/news/nath-bio-genes-india-628630"
  },
  "announcements": [
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding Related Party Transaction for the half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Other General Purpose",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding Investor Presentation on unaudited financial results for the period ended 30th sep 2019",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Investor Presentation",
      "datetime": "04-Nov-2019"
    },
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding 'Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.'.",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Updates",
      "datetime": "30-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nath Bio-Genes (India) Ltd has declared <strong>20%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Nath Bio-Genes falling/rising?

2025-12-06 01:25:11

Recent Price Movement and Market Performance

On 05-Dec, Nath Bio-Genes closed at ₹142.45, down by ₹3.4 or 2.33%, marking a continuation of a downward trend that has persisted over the last four trading sessions. During this period, the stock has lost nearly 9.84% in value, hitting a fresh 52-week low of ₹140.1 intraday. This decline is further accentuated by the stock’s underperformance against its sector, lagging by 3.08% on the day. The weighted average price indicates that a significant volume of shares traded closer to the day’s low, signalling selling pressure among investors.

Moreover, Nath Bio-Genes is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish sentiment prevailing...

Nath Bio-Genes (India) Stock Hits 52-Week Low at Rs.140.1 Amidst Prolonged Downtrend

2025-12-05 15:53:01

Nath Bio-Genes (India) has reached a fresh 52-week low of Rs.140.1, marking a significant decline amid a sustained downward trend over recent sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s sector and financial metrics.

Nath Bio-Genes (India) Stock Hits 52-Week Low at Rs.140.1 Amidst Continued Downtrend

2025-12-05 15:52:59

Nath Bio-Genes (India) has reached a new 52-week low of Rs.140.1, marking a significant decline amid a sustained downward trend over recent sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s financial and operational metrics.

Nath Bio-Genes Sees Revision in Market Assessment Amidst Challenging Fundamentals

2025-12-02 10:09:46

Nath Bio-Genes has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. The company’s recent performance metrics and investor participation trends have contributed to this updated assessment, signalling caution for stakeholders in the Other Agricultural Products sector.

Why is Nath Bio-Genes falling/rising?

2025-11-19 23:02:02

As of 19-Nov, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at Rs 160.65, which reflects a decrease of 3.0 points or 1.83%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.72% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of performance against the benchmark, the stock has shown negative returns over various periods, including a year-to-date decline of 14.66% compared to a 9.02% increase in the Sensex. There is no information available regarding positive or negative factors that could influence the stock's recent movement. Broader Market Context: In the context of the broader market, the Agri-Seeds sector has also seen a downturn, with a decline of 5.53%. While Nath Bio-Genes has outperformed its sector by 3.5% toda...

Nath Bio-Genes Q2 FY26: Seasonal Slump Masks Underlying Growth as Stock Struggles

2025-11-15 10:04:35

Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹320.00 crores, reported a consolidated net profit of ₹2.75 crores for Q2 FY26 (Jul-Sep'25), representing a sharp 92.62% quarter-on-quarter decline but a robust 147.75% year-on-year improvement. The dramatic sequential fall reflects the company's highly seasonal business model, where the first quarter typically captures the bulk of annual revenues during the peak agricultural season.

How has been the historical performance of Nath Bio-Genes?

2025-11-13 23:32:10

Answer: The historical performance of Nath Bio-Genes shows a consistent growth trend in net sales and profitability over the past four years. Breakdown: Nath Bio-Genes has demonstrated a steady increase in net sales, rising from 278.36 crore in March 2022 to 364.91 crore in March 2025. Total operating income followed the same upward trajectory, reaching 364.91 crore in March 2025. The company's total expenditure, excluding depreciation, also increased, amounting to 315.11 crore in March 2025, up from 241.18 crore in March 2022. Operating profit, excluding other income, remained relatively stable, with a slight decrease to 49.80 crore in March 2025 from 49.86 crore in March 2024, while the overall operating profit (PBDIT) increased to 54.35 crore in March 2025. Profit before tax improved significantly from a loss of 63.43 crore in March 2022 to a profit of 40.04 crore in March 2025. Profit after tax also sa...

How has been the historical performance of Nath Bio-Genes?

2025-11-12 23:19:03

Answer: The historical performance of Nath Bio-Genes shows a consistent growth trend in net sales and profitability over the past four years, culminating in the fiscal year ending March 2025. Breakdown: Nath Bio-Genes reported net sales of 364.91 Cr in March 2025, an increase from 332.62 Cr in March 2024, 301.36 Cr in March 2023, and 278.36 Cr in March 2022. The total operating income mirrored this growth, reaching 364.91 Cr in March 2025. Total expenditure, excluding depreciation, also rose to 315.11 Cr in March 2025 from 282.76 Cr in March 2024, reflecting increased manufacturing and distribution expenses. Operating profit (PBDIT) was 54.35 Cr in March 2025, slightly up from 50.49 Cr in March 2024, while profit before tax improved to 40.04 Cr from 38.12 Cr. Profit after tax reached 38.06 Cr in March 2025, compared to 36.17 Cr in March 2024, indicating a positive trend in profitability. The earnings per s...

Nath Bio-Genes Faces Shift to Bearish Outlook Amid Declining Investor Confidence

2025-11-11 08:34:31

Nath Bio-Genes (India) has undergone a recent evaluation adjustment, reflecting a shift in its technical outlook. The company has reported a -10.61% return over the past year and a decline in institutional investor participation. Additionally, it has experienced a -0.69% CAGR growth in operating profits over five years.

View All News

Announcement

Nath Bio-Genes (India) Limited - Other General Purpose

26-Nov-2019 | Source : NSE

Nath Bio-Genes (India) Limited has informed the Exchange regarding Related Party Transaction for the half year ended September 30, 2019.

Nath Bio-Genes (India) Limited - Investor Presentation

04-Nov-2019 | Source : NSE

Nath Bio-Genes (India) Limited has informed the Exchange regarding Investor Presentation on unaudited financial results for the period ended 30th sep 2019